Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Smith

Showing results (211-220 of 249) with videos related to

Pageof 25
Sort By:
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|July 7, 2026
"Everyone's Responsibility and No-One's Responsibility": A Thematic Analysis of a Roundtable on the Complex Problem of Secondary Stroke Prevention in AustraliaSeamus Barker, Dominique Cadilhac, Jan Cameron, et al.
Head & Neck|March 19, 2015
Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinomaMatthew G Fury, Han Xiao, Eric J Sherman, et al.
Antimicrobial Resistance and Infection Control|August 11, 2022
Risk of transmission of respiratory viruses during aerosol-generating medical procedures (AGMPs) revisited in the COVID-19 pandemic: a systematic reviewJenine Leal, Brenlea Farkas, Liza Mastikhina, et al.
Trials|September 17, 2021
Stepped care for depression at integrated chronic care centers (IC3) in Malawi: study protocol for a stepped-wedge cluster randomized controlled trialRyan K McBain, Owen Mwale, Todd Ruderman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancerMatthew G Fury, Eric Sherman, Donna Lisa, et al.
Environment International|January 24, 2026
Quantitative evaluation of genotoxicity data for risk assessment and regulatory decision-making: Time for a paradigm shiftBenjamin Sachse, Sebastian Schmeisser, Jan van Benthem, et al.
Plos One|September 27, 2013
Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitalsManal Tadros, Victoria Williams, Brenda L Coleman, et al.
Plos One|August 27, 2013
Loss of the nuclear receptor corepressor SLIRP compromises male fertilityShane M Colley, Larissa Wintle, Richelle Searles, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 7, 2024
Associations Between Chronic Rhinosinusitis and the Development of Non-Cystic Fibrosis BronchiectasisSo Lim Kim, Brian S Schwartz, Thanh-Huyen Vu, et al.
International Forum of Allergy & Rhinology|December 28, 2022
Climate change, the environment, and rhinologic diseaseJean Kim, Darryn W Waugh, Benjamin F Zaitchik, et al.
Pageof 25

Showing results (211-220 of 249) with videos related to

Sort By:
Pageof 25
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|July 7, 2026
"Everyone's Responsibility and No-One's Responsibility": A Thematic Analysis of a Roundtable on the Complex Problem of Secondary Stroke Prevention in AustraliaSeamus Barker, Dominique Cadilhac, Jan Cameron, et al.
Head & Neck|March 19, 2015
Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinomaMatthew G Fury, Han Xiao, Eric J Sherman, et al.
Antimicrobial Resistance and Infection Control|August 11, 2022
Risk of transmission of respiratory viruses during aerosol-generating medical procedures (AGMPs) revisited in the COVID-19 pandemic: a systematic reviewJenine Leal, Brenlea Farkas, Liza Mastikhina, et al.
Trials|September 17, 2021
Stepped care for depression at integrated chronic care centers (IC3) in Malawi: study protocol for a stepped-wedge cluster randomized controlled trialRyan K McBain, Owen Mwale, Todd Ruderman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancerMatthew G Fury, Eric Sherman, Donna Lisa, et al.
Environment International|January 24, 2026
Quantitative evaluation of genotoxicity data for risk assessment and regulatory decision-making: Time for a paradigm shiftBenjamin Sachse, Sebastian Schmeisser, Jan van Benthem, et al.
Plos One|September 27, 2013
Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitalsManal Tadros, Victoria Williams, Brenda L Coleman, et al.
Plos One|August 27, 2013
Loss of the nuclear receptor corepressor SLIRP compromises male fertilityShane M Colley, Larissa Wintle, Richelle Searles, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 7, 2024
Associations Between Chronic Rhinosinusitis and the Development of Non-Cystic Fibrosis BronchiectasisSo Lim Kim, Brian S Schwartz, Thanh-Huyen Vu, et al.
International Forum of Allergy & Rhinology|December 28, 2022
Climate change, the environment, and rhinologic diseaseJean Kim, Darryn W Waugh, Benjamin F Zaitchik, et al.
Pageof 25